v. 19 – Q3 2021
|Market Executive Summary||
Roadmap announced and Traceability Pilot underway: Food and Medicine Administration Proclamation 1112/2019
Codified as Directive “Pharmaceutical Products Traceability Directive No.43/2019”, published 19 August 2019
Scope is defined as “1. All pharmaceutical products registered in Ethiopia which are intended for human use” as well as “prescribed medicines, program medicines and medicines easily exposed to counterfeiting.”
September 2021: timelines revised, and next milestone confirmed (19 August 2021): Data Standard Compliance (focus imported medicines)
Proposed timeline: Phased implementation over 7 years (to 2026), starting with master data guidance, then batch coding leading to serialisation. Roll-out for each phase will start with pilot and be expanded stepwise for different product groups.
The phasing has now been confirmed: